Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2025 Earnings Call Transcript May 6, 2025
Arcutis Biotherapeutics, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.21.
Operator: Good day and welcome to Arcutis Biotherapeutics’ 2025 First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Please be advised that today’s conference is...
